Neutrophil-to-leukocyte ratio and admission glycemia as predictors of short-term death in very old elderlies with lobar intracerebral hemorrhage

BACKGROUND: The incidence of spontaneous intracerebral hemorrhage (SICH) is highest in very old elderlies (≥75 years). The increasing use of antithrombotic drugs is shifting the epidemiology of SICH towards predominance of lobar subtype, suggesting an incremented propensity of bleeding associated with underlying cerebral amyloid angiopathy. With population aging and antithrombotic use, a parallel raise of proportion of lobar SICH is occurring. Improvement of prognostication in this specific age group and SICH type is needed. Routine blood biomarkers can contribute to prediction of short-term mortality after SICH. OBJECTIVE: Our aim was to investigate the contribution of routine blood biomarkers for short-term mortality (30-days) in elderly patients with lobar SICH. METHODS: Retrospective analysis of consecutive 130 patients with ≥ 75 years and lobar SICH. The outcome was 30-day mortality. Logistic regression analysis was used to investigate whether admission routine biomarkers can be used as predictors. RESULTS: The case fatality was 40.8%. Admission glycaemia level, neutrophil to lymphocyte ratio and mean platelet volume were significantly different between groups (p = 0.001, p = 0.024, p = 0.038, respectively). There was no significant difference in all other routine biomarkers. On multivariate analysis, admission higher mean BG level (odds ratio [OR]: 1.010, 95% confidence interval [CI]: 1.001-1.019, p = 0.026) and neutrophil to lymphocyte ratio (OR: 1.070, 95%CI: 1.008-1.136, p = 0.027) emerged as predictors. CONCLUSION: In very old patients with lobar SICH, higher BG level and neutrophil to lymphocyte ratio are associated with increased risk of short-term death.

[1]  E. Tzavellas,et al.  Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review , 2022, Journal of Clinical Medicine.

[2]  Aijuan Yan,et al.  Association of Pre-stroke Frailty With Prognosis of Elderly Patients With Acute Cerebral Infarction: A Cohort Study , 2022, Frontiers in Neurology.

[3]  J. Mocco,et al.  2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. , 2022, Stroke.

[4]  J. Mocco,et al.  Prognostic Utility of Serum Biomarkers in Intracerebral Hemorrhage: A Systematic Review , 2021, Neurorehabilitation and neural repair.

[5]  S. Schwab,et al.  Disability-Adjusted Life-Years Associated With Intracerebral Hemorrhage and Secondary Injury. , 2021, JAMA network open.

[6]  A. Marreiros,et al.  Prediction of short-term prognosis in elderly patients with spontaneous intracerebral hemorrhage , 2021, European Geriatric Medicine.

[7]  M. Nozoe,et al.  Relationship between pre-stroke frailty status and short-term functional outcome in older patients with acute stroke-A mediation analysis. , 2021, Archives of gerontology and geriatrics.

[8]  Eric E. Smith,et al.  Statin treatment and cerebral microbleeds: A systematic review and meta-analysis , 2020, Journal of the Neurological Sciences.

[9]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[10]  J. Solé-Violán,et al.  Red blood cell distribution width and mortality of spontaneous intracerebral hemorrhage patients , 2020, Clinical Neurology and Neurosurgery.

[11]  Xi Li,et al.  Predictive Accuracy of Neutrophil-to-Lymphocyte Ratio on Long-Term Outcome in Patients with Spontaneous Intracerebral Hemorrhage. , 2019, World neurosurgery.

[12]  Gustavo Duque,et al.  Current and emerging biomarkers of frailty in the elderly , 2019, Clinical interventions in aging.

[13]  Andreas Luft,et al.  Global Burden of Stroke , 2018, Seminars in Neurology.

[14]  C. Sudlow,et al.  The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study , 2018, The Lancet Neurology.

[15]  M. Elkind,et al.  Potential Role of Blood Biomarkers in the Management of Nontraumatic Intracerebral Hemorrhage , 2014, Cerebrovascular Diseases.

[16]  Qing-Wu Yang,et al.  Inflammation in intracerebral hemorrhage: From mechanisms to clinical translation , 2014, Progress in Neurobiology.

[17]  D. Krieger,et al.  European Research Priorities for Intracerebral Haemorrhage , 2011, Cerebrovascular Diseases.

[18]  J. Ferro,et al.  Outcome of first-ever acute ischemic stroke in the elderly. , 2011, Archives of gerontology and geriatrics.

[19]  T. Brott,et al.  Update in Intracerebral Hemorrhage , 2011, The Neurohospitalist.

[20]  Seung-Hoon Lee,et al.  Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study , 2010, Diabetologia.

[21]  K. Furie,et al.  Molecular biomarkers in stroke diagnosis and prognosis. , 2009, Biomarkers in medicine.

[22]  D G Altman,et al.  Statistics in medical journals: some recent trends. , 2000, Statistics in medicine.

[23]  T. Miyatake,et al.  Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly , 1993, Journal of the Neurological Sciences.

[24]  C. Cordonnier,et al.  Classification of Intracerebral Haemorrhages , 2015 .

[25]  M. Arad,et al.  Short-term functional outcome of ischemic stroke in the elderly: a comparative study of atrial fibrillation and non-atrial fibrillation patients. , 2014, Archives of gerontology and geriatrics.

[26]  Robert H Christenson,et al.  Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. , 2010, Clinical chemistry.

[27]  N. Dudley Stroke in the very old: clinical presentations and outcomes. , 2008, Age and ageing.